About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
Mar 31, 2022... REHOVOT, ISRAEL—March 31, 2022—Genetic mutations linked to a disease often spell bad news. Mutations in over 25 genes, for example, are associated with amyotrophic lateral sclerosis, or ALS, and they all increase the risk of developing this incurable disorder. Now, a research team headed by Prof. Eran Hornstein of the Weizmann Institute of Science has linked a new gene to ALS, but this one contains mutations of a different sort: They seem to play a defensive, rather than an offensive, role in the disease.
https://www.weizmann-usa.org/news-media/in-the-news/a-new-way-to-measure-creativity/
Apr 07, 2022... Creativity is crucial—at the heart of human endeavors ranging from art to entrepreneurship. It’s also notoriously hard to study. Usually in psychological tests we see whether people produce a particular predetermined response to a particular question. The essence of creativity, however, is to spontaneously make something new, something no one could predict beforehand. The few measures of creativity we have are more than 50 years old, and they are hard to score and often unreliable.
https://www.weizmann-usa.org/news-media/feature-stories/a-new-gene-linked-to-als/
May 25, 2022... ALS (amyotrophic lateral sclerosis, also known by the name Lou Gehrig’s disease) is a rare – and devastating – neurological disease. Many of us probably didn’t know about it until the Ice Bucket Challenge a few years ago. So what research developments on the disease have been made since then? ALS Awareness Month is a chance to reflect on that and to share a recent discovery at Weizmann that could slow or prevent the disease.
May 31, 2022... REHOVOT, ISRAEL—May 31, 2022—Ketamine, a well-known anesthetic used in smaller doses as a party drug, was hailed as a “new hope for depression” in a Time magazine cover story in 2017. Two years later, the arrival of the first ketamine-based antidepressant – the nasal spray esketamine, made by Johnson & Johnson – was applauded as the most exciting development in the treatment of mood disorders in decades. Yet the U.S. Food and Drug Administration still limits the spray’s use. It is mainly given to depressed patients who have not been helped by other therapies – in part, because the new drug’s mechanism of action is insufficiently understood, leading to concerns over its safety.
Jun 24, 2022... REHOVOT, ISRAEL—June 23, 2022—Weizmann Institute of Science researchers have found that people may have a tendency to form friendships with individuals who have a similar body odor. The researchers were even able to predict the quality of social interactions between complete strangers by first “smelling” them with a device known as an electronic nose, or eNose. These findings, published today in Science Advances, suggest that the sense of smell may play a larger role in human social interactions than previously thought.
Jul 07, 2022...
NEW YORK, NY—July 7, 2022—The American Committee for the Weizmann Institute of Science, a nonprofit developing philanthropic support for the Weizmann Institute of Science in Rehovot, Israel, announced today that four Detroit-area philanthropists have recently committed highly impactful gifts to support breakthrough research initiatives.
Closing out their Fiscal Year on June 30, 2022, the American Committee recognizes their generous Michigan philanthropists for their leadership, dedication, and vision that will deeply impact global health, medicine, education, technology, and more.
Jul 14, 2022...
The American Committee for the Weizmann Institute of Science (ACWIS) has announced major gifts from four Detroit-area philanthropists in support of programs and initiatives at the Weizmann Institute of Science in Rehovot, Israel.
The gifts will establish or bolster contributor-named centers and institutes that extend the capacity of Weizmann’s scientific research initiatives in global health, medicine, and science education. No gift amounts were disclosed.
Jul 19, 2022...
The American Committee for the Weizmann Institute of Science, a nonprofit developing philanthropic support for the Weizmann Institute of Science in Rehovot, Israel, announced that four Detroit-area philanthropists have recently committed highly impactful gifts to support breakthrough research initiatives.
The American Committee recognizes these generous Michigan philanthropists for their leadership, dedication and vision that will deeply impact global health, medicine, education, technology and more.
https://www.weizmann-usa.org/news-media/feature-stories/new-hope-for-depression/
Jul 15, 2022...
According to the World Health Organization, depression afflicts nearly 300 million people worldwide. Yet despite decades of research, there are very few new treatments, and we still have so much to learn about how depression itself works.
A new study published in Neuron – conducted at the Weizmann Institute of Science and at the Max Planck Institute of Psychiatry in Munich, Germany, in collaboration with the Helmholtz Zentrum, Munich – might lead to a better understanding of depression itself and increase the treatment options. These developments could help address two challenges that many people, and especially underrepresented groups, face when it comes to depression: stigma and lack of options for care. In honor of National Minority Mental Health Awareness Month, we want to acknowledge those unique challenges and share Weizmann research that provides new hope for depression.
Jan 25, 2023...
Researchers have for years tried to discover what determines “resilience to stress,” a term describing the ability to adapt to difficult situations and to overcome adversity. Is it acquired through experience, or is there a tendency to easily recover from stress possibly ingrained in us from a very early age or even from birth?
A new study lead by Prof. Gil Levkowitz of the molecular cell biology and molecular neuroscience departments at the Weizmann Institute of Science in Rehovot has revealed an important piece of this puzzle. The study examined zebrafish – small, black-and-white-striped, transparent fish whose natural habitat spans rivers, ponds and rice paddies in Pakistan, Myanmar, Nepal and India.